Literature DB >> 8947917

Functional analysis of cloned opioid receptors in transfected cell lines.

E T Piros1, T G Hales, C J Evans.   

Abstract

Opioids modulate numerous central and peripheral processes including pain perception neuroendocrine secretion and the immune response. The opioid signal is transduced from receptors through G proteins to various different effectors. Heterogeneity exists at all levels of the transduction process. There are numerous endogenous ligands with differing selectivities for at least three distinct opioid receptors (mu, delta, kappa). G proteins activated by opioid receptors are generally of the pertussis toxin-sensitive Gi/Go class, but there are also opioid actions that are thought to involve Gq and cholera toxin-sensitive G proteins. To further complicate the issue, the actions of opioid receptors may be mediated by G-protein alpha subunits and/or beta gamma subunits. Subsequent to G protein activation several effectors are known to orchestrate the opioid signal. For example activation of opioid receptors increases phosphatidyl inositol turnover, activates K+ channels and reduces adenylyl cyclase and Ca2+ channel activities. Each of these effectors shows considerable heterogeneity. In this review we examine the opioid signal transduction mechanism. Several important questions arise: Why do opioid ligands with similar binding affinities have different potencies in functional assays? To which Ca2+ channel subtypes do opioid receptors couple? Do opioid receptors couple to Ca2+ channels through direct G protein interactions? Does the opioid-induced inhibition of vesicular release occur through modulation of multiple effectors? We are attempting to answer these questions by expressing cloned opioid receptors in GH3 cells. Using this well characterized system we can study the entire opioid signal transduction process from ligand-receptor interaction to G protein-effector coupling and subsequent inhibition of vesicular release.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8947917     DOI: 10.1007/bf02532368

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  75 in total

1.  Inhibition of the omega-conotoxin-sensitive calcium current by distinct G proteins.

Authors:  R Taussig; S Sanchez; M Rifo; A G Gilman; F Belardetti
Journal:  Neuron       Date:  1992-04       Impact factor: 17.173

2.  Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration.

Authors:  A W Mudge; S E Leeman; G D Fischbach
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

3.  Fast, local signal transduction between the mu opioid receptor and Ca2+ channels.

Authors:  T J Wilding; M D Womack; E W McCleskey
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

4.  Cloning and expression of an isoform of the rat mu opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1.

Authors:  A Zimprich; T Simon; V Höllt
Journal:  FEBS Lett       Date:  1995-02-13       Impact factor: 4.124

5.  Modulation of Ca2+ channels by G-protein beta gamma subunits.

Authors:  S Herlitze; D E Garcia; K Mackie; B Hille; T Scheuer; W A Catterall
Journal:  Nature       Date:  1996-03-21       Impact factor: 49.962

Review 6.  Facilitation of Ca2+ current in excitable cells.

Authors:  A C Dolphin
Journal:  Trends Neurosci       Date:  1996-01       Impact factor: 13.837

Review 7.  The role of G-protein beta gamma subunits in signal transduction.

Authors:  S Müller; M J Lohse
Journal:  Biochem Soc Trans       Date:  1995-02       Impact factor: 5.407

8.  mu and delta opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells.

Authors:  K L Laugwitz; S Offermanns; K Spicher; G Schultz
Journal:  Neuron       Date:  1993-02       Impact factor: 17.173

9.  The cloned kappa opioid receptor couples to an N-type calcium current in undifferentiated PC-12 cells.

Authors:  M Tallent; M A Dichter; G I Bell; T Reisine
Journal:  Neuroscience       Date:  1994-12       Impact factor: 3.590

10.  Inhibition of spinothalamic tract cells and interneurons by brain stem stimulation in the monkey.

Authors:  W D Willis; L H Haber; R F Martin
Journal:  J Neurophysiol       Date:  1977-07       Impact factor: 2.714

View more
  13 in total

1.  A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia.

Authors:  Kassi Psifogeorgou; Kassi Psigfogeorgou; Dimitra Terzi; Maria Martha Papachatzaki; Artemis Varidaki; Deveroux Ferguson; Stephen J Gold; Venetia Zachariou
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

2.  Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness.

Authors:  J Zhang; S S Ferguson; L S Barak; S R Bodduluri; S A Laporte; P Y Law; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

3.  Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.

Authors:  Michael R Bruchas; Tara A Macey; Janet D Lowe; Charles Chavkin
Journal:  J Biol Chem       Date:  2006-04-28       Impact factor: 5.157

4.  Mechanisms of μ-opioid receptor inhibition of NMDA receptor-induced substance P release in the rat spinal cord.

Authors:  Wenling Chen; Helena S Ennes; James A McRoberts; Juan Carlos Marvizón
Journal:  Neuropharmacology       Date:  2017-10-16       Impact factor: 5.250

5.  Regulation of nonsmall-cell lung cancer stem cell like cells by neurotransmitters and opioid peptides.

Authors:  Jheelam Banerjee; Arokya M S Papu John; Hildegard M Schuller
Journal:  Int J Cancer       Date:  2015-07-02       Impact factor: 7.396

6.  Generation of a KOR-Cre knockin mouse strain to study cells involved in kappa opioid signaling.

Authors:  Xiaoyun Cai; Huizhen Huang; Marissa S Kuzirian; Lindsey M Snyder; Megumi Matsushita; Michael C Lee; Carolyn Ferguson; Gregg E Homanics; Alison L Barth; Sarah E Ross
Journal:  Genesis       Date:  2015-12-18       Impact factor: 2.487

7.  Characterization of opioid receptors that modulate nociceptive neurotransmission in the trigeminocervical complex.

Authors:  R J Storer; S Akerman; P J Goadsby
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

8.  Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase.

Authors:  Michael R Bruchas; Tao Yang; Selena Schreiber; Mia Defino; Steven C Kwan; Shuang Li; Charles Chavkin
Journal:  J Biol Chem       Date:  2007-08-16       Impact factor: 5.157

Review 9.  Development of κ opioid receptor antagonists.

Authors:  F Ivy Carroll; William A Carlezon
Journal:  J Med Chem       Date:  2013-02-14       Impact factor: 7.446

Review 10.  Ionic storm in hypoxic/ischemic stress: can opioid receptors subside it?

Authors:  Dongman Chao; Ying Xia
Journal:  Prog Neurobiol       Date:  2009-12-28       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.